Associations of microalbuminuria with brain atrophy and white matter hyperintensities in hypertensive sibships

[1]  Takeo Kato,et al.  Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects , 2007, Journal of the Neurological Sciences.

[2]  Chris Zarow,et al.  Cognitive impact of subcortical vascular and Alzheimer's disease pathology , 2006, Annals of neurology.

[3]  G. Curhan,et al.  Screening, monitoring, and treatment of albuminuria: Public health perspectives. , 2006, Journal of the American Society of Nephrology : JASN.

[4]  L. Kuller,et al.  The association of microalbuminuria with clinical cardiovascular disease and subclinical atherosclerosis in the elderly: the Cardiovascular Health Study. , 2006, Atherosclerosis.

[5]  E. Boerwinkle,et al.  Influence of genomic loci on measures of chronic kidney disease in hypertensive sibships. , 2006, Journal of the American Society of Nephrology : JASN.

[6]  E. Boerwinkle,et al.  A comparison of serum creatinine-based methods for identifying chronic kidney disease in hypertensive individuals and their siblings. , 2006, American journal of hypertension.

[7]  J. Sowers,et al.  The Cardiometabolic Syndrome as a Cardiovascular Risk Factor , 2005, The American journal of the medical sciences.

[8]  D. Knopman,et al.  Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort , 2005, Neurology.

[9]  Clifford R Jack,et al.  Genomic Susceptibility Loci for Brain Atrophy in Hypertensive Sibships From the GENOA Study , 2005, Hypertension.

[10]  Norman J Beauchamp,et al.  Incidence, Manifestations, and Predictors of Worsening White Matter on Serial Cranial Magnetic Resonance Imaging in the Elderly: The Cardiovascular Health Study , 2005, Stroke.

[11]  E. Boerwinkle,et al.  Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study. , 2004, Archives of internal medicine.

[12]  E. Boerwinkle,et al.  Familial aggregation of hypertension treatment and control in the Genetic Epidemiology Network of Arteriopathy (GENOA) study. , 2004, The American journal of medicine.

[13]  C. Iadecola.  Neurovascular regulation in the normal brain and in Alzheimer's disease , 2004, Nature Reviews Neuroscience.

[14]  P. Hof,et al.  Cortical Microinfarcts and Demyelination Significantly Affect Cognition in Brain Aging , 2004, Stroke.

[15]  M. Fornage,et al.  Heritability of Leukoaraiosis in Hypertensive Sibships , 2004, Hypertension.

[16]  R. Klein,et al.  Retinal microvascular changes and MRI signs of cerebral atrophy in healthy, middle-aged people. , 2004, Neurology.

[17]  O. Wiestler,et al.  Vascular Pathology in Alzheimer Disease: Correlation of Cerebral Amyloid Angiopathy and Arteriosclerosis/Lipohyalinosis with Cognitive Decline , 2003, Journal of neuropathology and experimental neurology.

[18]  P. J. Koudstaal,et al.  Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI , 2003, Diabetologia.

[19]  C. Lewis,et al.  A Genome-Wide Scan for Urinary Albumin Excretion in Hypertensive Families , 2003, Hypertension.

[20]  G. Eknoyan,et al.  National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification , 2003, Annals of Internal Medicine.

[21]  P. Sandercock,et al.  Is Breakdown of the Blood-Brain Barrier Responsible for Lacunar Stroke, Leukoaraiosis, and Dementia? , 2003, Stroke.

[22]  R. Donnelly,et al.  Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes. , 2003, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[23]  T. Beach,et al.  Cortical and Leptomeningeal Cerebrovascular Amyloid and White Matter Pathology in Alzheimer’s Disease , 2003, Molecular medicine.

[24]  Matthijs Oudkerk,et al.  Incidence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study , 2003, Stroke.

[25]  W. Markesbery,et al.  Cerebrovascular Pathology and Dementia in Autopsied Honolulu‐Asia Aging Study Participants , 2002, Annals of the New York Academy of Sciences.

[26]  R. Klein,et al.  Retinal Microvascular Abnormalities and Cognitive Impairment in Middle-Aged Persons: The Atherosclerosis Risk in Communities Study , 2002, Stroke.

[27]  E. Englund.  Neuropathology of White Matter Lesions in Vascular Cognitive Impairment , 2002, Cerebrovascular Diseases.

[28]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[29]  Matthijs Oudkerk,et al.  Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam scan study , 2002, Annals of neurology.

[30]  C. Jack,et al.  FLAIR histogram segmentation for measurement of leukoaraiosis volume , 2001, Journal of magnetic resonance imaging : JMRI.

[31]  S. Yusuf,et al.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. , 2001, JAMA.

[32]  W. Jagust,et al.  Neuropathologic Substrates of Ischemic Vascular Dementia , 2000, Journal of neuropathology and experimental neurology.

[33]  Nick Bryan,et al.  Clinical Correlates of Ventricular and Sulcal Size on Cranial Magnetic Resonance Imaging of 3,301 Elderly People , 1999, Neuroepidemiology.

[34]  C. DeCarli,et al.  Midlife cardiovascular risk factors and brain morphology in identical older male twins , 1999, Neurology.

[35]  T. Manolio,et al.  Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. , 1998, Archives of neurology.

[36]  M. Esiri,et al.  Neuropathological assessment of the lesions of significance in vascular dementia , 1997, Journal of neurology, neurosurgery, and psychiatry.

[37]  L. Fried,et al.  Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. , 1996, Stroke.

[38]  B. Brenner,et al.  Hypertension: Pathophysiology, Diagnosis, and Management , 1994 .

[39]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[40]  Aric Invest.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators , 1989 .

[41]  A. Folsom,et al.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.

[42]  Niels D Prins,et al.  Retinal vessel diameters and cerebral small vessel disease: the Rotterdam Scan Study. , 2006, Brain : a journal of neurology.

[43]  A Hofman,et al.  Homocysteine and brain atrophy on MRI of non-demented elderly. , 2003, Brain : a journal of neurology.

[44]  J. Toole,et al.  The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study. , 1997, Neuroepidemiology.

[45]  J. Ledingham.  Chronic renal failure and dialysis. , 1974, Nursing mirror and midwives journal.